These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors. Park H; Li M; Choi J; Cho H; Ham SW Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977 [TBL] [Abstract][Full Text] [Related]
4. A knowledge-based weighting approach to ligand-based virtual screening. Stiefl N; Zaliani A J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening. Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313 [TBL] [Abstract][Full Text] [Related]
7. Recent development and application of virtual screening in drug discovery: an overview. Hou T; Xu X Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130 [TBL] [Abstract][Full Text] [Related]
8. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Tropsha A; Golbraikh A Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786 [TBL] [Abstract][Full Text] [Related]
9. Current status of virtual screening as analysed by target class. Stoermer MJ Med Chem; 2006 Jan; 2(1):89-112. PubMed ID: 16787359 [TBL] [Abstract][Full Text] [Related]
10. Virtual screening of chemical libraries. Shoichet BK Nature; 2004 Dec; 432(7019):862-5. PubMed ID: 15602552 [TBL] [Abstract][Full Text] [Related]
11. Towards improving compound selection in structure-based virtual screening. Waszkowycz B Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797 [TBL] [Abstract][Full Text] [Related]
12. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity. Martin E; Mukherjee P; Sullivan D; Jansen J J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971 [TBL] [Abstract][Full Text] [Related]
13. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery. Pozzan A Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558 [TBL] [Abstract][Full Text] [Related]
14. Scaffold composition and biological relevance of screening libraries. Shelat AA; Guy RK Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770 [TBL] [Abstract][Full Text] [Related]
15. Virtual screening: an endless staircase? Schneider G Nat Rev Drug Discov; 2010 Apr; 9(4):273-6. PubMed ID: 20357802 [TBL] [Abstract][Full Text] [Related]
16. Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates. Kirchmair J; Distinto S; Schuster D; Spitzer G; Langer T; Wolber G Curr Med Chem; 2008; 15(20):2040-53. PubMed ID: 18691055 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screening. Finn J; Stidham M; Hilgers M; G C K Bioorg Med Chem Lett; 2008 Jul; 18(14):3932-7. PubMed ID: 18590962 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening in drug discovery -- a computational perspective. Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867 [TBL] [Abstract][Full Text] [Related]
19. Reporting data from high-throughput screening of small-molecule libraries. Inglese J; Shamu CE; Guy RK Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769 [TBL] [Abstract][Full Text] [Related]
20. The many roles of computation in drug discovery. Jorgensen WL Science; 2004 Mar; 303(5665):1813-8. PubMed ID: 15031495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]